These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16020508)

  • 1. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
    Li L; Godfrey WR; Porter SB; Ge Y; June CH; Blazar BR; Boussiotis VA
    Blood; 2005 Nov; 106(9):3068-73. PubMed ID: 16020508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell effector function and anergy avoidance are quantitatively linked to cell division.
    Wells AD; Walsh MC; Sankaran D; Turka LA
    J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
    Inaba H; Geiger TL
    Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function.
    Rowell EA; Walsh MC; Wells AD
    J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
    Godfrey WR; Spoden DJ; Ge YG; Baker SR; Liu B; Levine BL; June CH; Blazar BR; Porter SB
    Blood; 2005 Jan; 105(2):750-8. PubMed ID: 15374887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.
    Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A
    Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
    Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
    PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
    Lupino E; Buccinnà B; Ramondetti C; Lomartire A; De Marco G; Ricotti E; Tovo PA; Rinaudo MT; Piccinini M
    Immunology; 2010 Oct; 131(2):231-41. PubMed ID: 20465575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
    Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
    J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.
    Chen D; Heath V; O'Garra A; Johnston J; McMahon M
    J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells.
    Hickman SP; Yang J; Thomas RM; Wells AD; Turka LA
    J Immunol; 2006 Aug; 177(4):2186-94. PubMed ID: 16887978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
    Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
    J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
    Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
    Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
    Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
    Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells.
    Harris JE; Bishop KD; Phillips NE; Mordes JP; Greiner DL; Rossini AA; Czech MP
    J Immunol; 2004 Dec; 173(12):7331-8. PubMed ID: 15585857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling.
    Zanin-Zhorov A; Cahalon L; Tal G; Margalit R; Lider O; Cohen IR
    J Clin Invest; 2006 Jul; 116(7):2022-32. PubMed ID: 16767222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.
    Grader-Beck T; van Puijenbroek AA; Nadler LM; Boussiotis VA
    Blood; 2003 Feb; 101(3):998-1006. PubMed ID: 12393539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.